Related references
Note: Only part of the references are listed.High levels of bcl-2 protein expression do not correlate with genetic abnormalities but predict worse prognosis in patients with lymphoblastic lymphoma
Yajun Gu et al.
TUMOR BIOLOGY (2013)
Prognostic value of bcl-2 expression among women with breast cancer in Libya
Eramah Ermiah et al.
TUMOR BIOLOGY (2013)
Signatures of tumor-immune interactions as biomarkers for breast cancer prognosis
Masoud H. Manjili et al.
FUTURE ONCOLOGY (2012)
Mitochondrial Biogenesis Drives Tumor Cell Proliferation
Ubaldo E. Martinez-Outschoorn et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
The Mammalian Anti-Proliferative BTG/Tob Protein Family
G. Sebastiaan Winkler
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
B cell translocation gene 1 contributes to antisense Bcl-2-mediated apoptosis in breast cancer cells
Rita Nahta et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Role of antiproliferative B cell translocation gene-1 as an apoptotic sensitizer in activation-induced cell death of brain microglia
H Lee et al.
JOURNAL OF IMMUNOLOGY (2003)
Nuclear factor-kappa B and cancer: its role in prevention and therapy
AC Bharti et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Development - Stromal effects on mammary gland development and breast cancer
BS Wiseman et al.
SCIENCE (2002)
Combined evaluation of expressions of p53 and p21 proteins as prognostic factors for patients with gastric carcinoma
T Okuyama et al.
ONCOLOGY (2002)
In search of a function for the TIS21/PC3/BTG1/TOB family
S Matsuda et al.
FEBS LETTERS (2001)
The gene PC3TIS21/BTG2, prototype member of the PC3/BTG/TOB family:: Regulator in control of cell growth, differentiation, and DNA repair?
F Tirone
JOURNAL OF CELLULAR PHYSIOLOGY (2001)
Share Paper
